We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LNT:NASDAQAlliant Energy Corporation Analysis

Data as of 2026-03-11 - not real-time

$71.04

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Alliant Energy (LNT) is trading well above its 20‑day, 50‑day and 200‑day moving averages, a classic sign of a bullish technical backdrop, and the recent surge in volume supports the upward momentum. The RSI sits in the mid‑50s, indicating no immediate over‑bought pressure, while the MACD histogram has turned negative, hinting at a possible short‑term pull‑back despite the broader bullish trend.
Fundamentally, the company posted a 9% revenue increase and beat Q4 earnings estimates, driven by growing data‑center demand and disciplined cost controls. However, a high debt‑to‑equity ratio above 150%, negative free‑cash‑flow and a PE multiple that exceeds the industry average suggest the stock is priced on optimism. The 2.9% dividend yield with a 64% payout ratio remains attractive, but sustainability will depend on improving cash generation. Analysts project modest upside to the mid‑$70s, reflecting confidence in earnings growth targets through 2029, yet the current price appears stretched relative to its DCF fair‑value estimate.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key moving averages
  • Increasing trading volume
  • MACD bearish divergence signaling near‑term correction

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth and data‑center driven earnings outlook
  • Attractive dividend yield with stable payout
  • Analyst consensus target price indicating modest upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Regulated utility business provides revenue stability
  • High leverage and negative free cash flow elevate financial risk
  • Consistent dividend increases support income‑focused investors

Key Metrics & Analysis

Financial Health

Revenue Growth9.00%
Profit Margin18.57%
P/E Ratio22.6
ROE11.30%
ROA2.64%
Debt/Equity168.08
P/B Ratio2.5
Op. Cash Flow$1.2B
Free Cash Flow$-1369250048
Industry P/E20.7

Technical Analysis

TrendBullish
RSI56.9
Support$66.89
Resistance$72.65
MA 20$70.99
MA 50$68.09
MA 200$65.74
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value$19.09
Target Price$74.70
Upside/Downside5.15%
GradeOvervalued
TypeBlend
Dividend Yield2.90%

Risk Assessment

Beta0.22
Volatility16.98%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.